patents

Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Novartis' MS patent win also a win for Celgene's impending MS drug: analyst
Medical Marketing and Media
Celgene
Novartis
ozanimod
Gilenya
MS
multiple sclerosis
patents
Flag link:
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
MS patent win boosts Novartis’ Gilenya, helps Celgene and maybe Biogen too
Fierce Pharma
patents
Novartis
MS
Gilenya
Celgene
exclusivity
Flag link:
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
CP Wire
Eagle Pharmaceuticals
Bendeka
Teva Pharmaceuticals
CLL
patents
Flag link:
AI Will Not Threaten Pharma Patents – Not This Way
AI Will Not Threaten Pharma Patents – Not This Way
Science Translational Medicine
artificial intelligence
drug discovery
patents
Flag link:
Allergan: This $64,000 Question Could Kill Restasis IPR Appeal
Allergan: This $64,000 Question Could Kill Restasis IPR Appeal
NY Shock Exchange
Allergan
Restasis
IPR
patents
Flag link:
FDA Updates List of Drugs Without Generic Competition
FDA Updates List of Drugs Without Generic Competition
RAPS.org
FDA
generics
patents
Flag link:
U.S. District Court rules in favor of Lilly's Alimta patent
U.S. District Court rules in favor of Lilly's Alimta patent
Yahoo/Reuters
Eli Lilly
Alimta
Hospira
Dr Reddy's
generics
patents
Flag link:
Why is AbbVie’s tax rate so low? Humira patents cached in Bermuda: Reuters
Why is AbbVie’s tax rate so low? Humira patents cached in Bermuda: Reuters
Fierce Pharma
AbbVie
taxes
Bermuda
Humira
patents
Flag link:
Here's Why Acorda Therapeutics Rose as Much as 30.3% Today
Here's Why Acorda Therapeutics Rose as Much as 30.3% Today
Motley Fool
Acorda Therapeutics
AMPYRA
patents
Flag link:
Balm for Gilead: Unclean Hands Render Patents Unenforceable
Balm for Gilead: Unclean Hands Render Patents Unenforceable
JD Supra
Merck
Gilead Sciences
patents
hepatitis C
Flag link:
Allergan's tribal licensing deal, opposed by tech giants, gets appeals court scrutiny
Allergan's tribal licensing deal, opposed by tech giants, gets appeals court scrutiny
Fierce Pharma
Allergan
patents
Flag link:
Tribe taking steps to ‘ramp up’ drug patent business
Tribe taking steps to ‘ramp up’ drug patent business
Drug Delivery Business News
Native Americans
Allergan
generics
patents
Flag link:
Stryker’s Howmedica owes $13m in fees in Zimmer Biomet patent spat
Stryker’s Howmedica owes $13m in fees in Zimmer Biomet patent spat
Mass Device
Stryker
Homedica
Zimmer Biomet
patents
devices
Flag link:
Indivior Reaches Patent Infringement Settlement With Par Pharmaceutical Over Suboxone
Indivior Reaches Patent Infringement Settlement With Par Pharmaceutical Over Suboxone
CP Wire
Individor
Par Pharmaceutical
Suboxone Film
Suboxone
patents
Flag link:
Judge sanctions Boston Scientific lawyers in Nevro patent row
Judge sanctions Boston Scientific lawyers in Nevro patent row
Mass Device
Boston Scientific
Nevro
devices
patents
neurostimulation
Flag link:
Lilly, Pfizer, Sanofi lead in patent litigation, report says
Lilly, Pfizer, Sanofi lead in patent litigation, report says
Biopharma Dive
Eli Lilly
Sanofi
Pfizer
patents
patent lawsuits
FDA
Flag link:
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
Kura Recieves New Patent for Tipifarnib in Lymphoma and Acute Myeloid Leukemia
CP Wire
Kura Oncology
tipifarnib
patents
AML
PTCL
Flag link:
New Patent Related Suit Against Shire Could Have Value Into the Billions
New Patent Related Suit Against Shire Could Have Value Into the Billions
CP Wire
Shire
Vyvanse
fraud
patents
Flag link:
U.S. court upholds dismissal of $200 million Merck verdict against Gilead
U.S. court upholds dismissal of $200 million Merck verdict against Gilead
Reuters
Merck
Gilead Sciences
patents
hepatitis C
Flag link:
Interview With Hatch-Waxman Expert Kurt Karst
Interview With Hatch-Waxman Expert Kurt Karst
CP Wire
FDA
Hatch Waxman Act
patents
Flag link:

Pages